Zymeworks, Inc. (ZYME)
23.17
+0.34
(+1.49%)
USD |
NASDAQ |
Feb 12, 16:00
23.34
+0.17
(+0.73%)
Pre-Market: 09:26
Zymeworks Free Cash Flow : -64.45M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Jazz Pharmaceuticals Plc | 1.282B |
| Johnson & Johnson | 19.70B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| CorMedix, Inc. | 74.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.92M |
| Cash from Investing (Quarterly) | 0.31M |
| Cash from Financing (Quarterly) | -2.497M |
| Free Cash Flow Per Share (Quarterly) | -0.4267 |
| Free Cash Flow to Equity (Quarterly) | -32.55M |
| Free Cash Flow to Firm (Quarterly) | -32.33M |
| Free Cash Flow Yield | -3.67% |